Trials / Terminated
TerminatedNCT01377909
HCV Treatment With Fluvastatin, Simvastatin to Improve Interferon Sensitivity
An Investigator-initiated Pilot Study Using Statins to Improve the Anti-HCV Response to Peginterferon Alfa 2-b and Ribavirin in Previous Non-responders
- Status
- Terminated
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Bader, Ted, M.D. · Individual
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Objective: The goal is to improve peginterferon sensitivity in previous poor responders. "Sensitivity" here means the host's ability to kill more HCV. Design: Twenty poor responders to prior PIFN/RBV will be given 48 weeks of statin monotherapy. Veterans and civilians between the ages of 18 and 70 are eligible.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | statin | daily statin orally for 48 weeks |
Timeline
- Start date
- 2012-03-01
- Primary completion
- 2013-08-01
- Completion
- 2013-08-01
- First posted
- 2011-06-22
- Last updated
- 2013-08-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01377909. Inclusion in this directory is not an endorsement.